Normal carcinoembryonic antigen indicates benefit from perioperative chemotherapy to gastric carcinoma patients
Authors:
- Ying-Bo ChenYCYing-Bo Chen
- Yuan-Fang LiYLYuan-Fang Li
- Xing-Yu FengXFXing-Yu Feng
- Zhi-Wei ZhouZZZhi-Wei Zhou
- Xiu-Hong YuanXYXiu-Hong Yuan
- Chao-Nan QianCQChao-Nan Qian
Open Access
- 1 January 2012
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 18 (29) , 3910-3916
Abstract
AIM: To evaluate pretreatment serum carcinoembryonic antigen (CEA) as a predictor of survival for patients with locally advanced gastric cancer receiving perioperative chemotherapy. METHODS: We retrospectively studied a cohort of 228 gastric cancer patients who underwent D2 gastrectomy combined with chemotherapy at the Sun Yat-sen University Cancer Center between January 2005 and December 2009. Among them, 168 patients received 6-12 cycles of oxaliplatin-based adjuvant (post-operative) chemotherapy, while 60 received perioperative chemotherapy (2 cycles of FOLFOX6 or XELOX before surgery and 4-10 cycles after surgery). Serum CEA was measured using an enzyme immunoassay. The follow-up lasted until December 2010. RESULTS: In the group that had elevated serum CEA, the difference in survival time between patients receiving perioperative chemotherapy and those receiving adjuvant chemotherapy had no statistical significance (P > 0.05). However, in the group that had normal serum CEA, patients receiving perioperative chemotherapy had a longer survival time. In multivariate analysis, T staging and lymph node metastatic rate were independent prognostic factors for the patients. Perioperative chemotherapy improved the overall survival of patients who had a normal pretreatment CEA level (P = 0.070). CONCLUSION: Normal pretreatment serum CEA is a predictor of survival for patients receiving perioperative chemotherapy.Keywords
This publication has 34 references indexed in Scilit:
- Prognostic value of the lymph node ratio in stage III colorectal cancerChinese Journal of Cancer, 2012
- Spatial autocorrelation calculations of the nine malignant neoplasms in Taiwan in 2005-2009: a gender comparison studyChinese Journal of Cancer, 2011
- Cost-benefit analysis of screening for esophageal and gastric cardiac cancerChinese Journal of Cancer, 2011
- [A case of advanced gastric cancer with obstructive jaundice due to multiple liver metastasis successfully treated with the following combination therapy of CPT-11 and cisplatin after combination therapy of paclitaxel and TS-1].2007
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Inhibition of endogenous carcinoembryonic antigen (CEA) increases the apoptotic rate of colon cancer cells and inhibits metastatic tumor growthClinical & Experimental Metastasis, 2002
- Tumor Markers in Monitoring Response to Chemotherapy for Patients with Gastric CancerJapanese Journal of Clinical Oncology, 1999
- CEA, CA 19-9, and CA-50 in Monitoring Gastric CarcinomaAmerican Journal of Clinical Oncology, 1997
- Adenovirus-mediated prodrug gene therapy for carcinoembryonic antigen-producing human gastric carcinoma cells in vitro.1996
- Prognostic value of preoperative serum CEA level compared to clinical staging: Ii. Stomach cancerBritish Journal of Cancer, 1982